Engineered FnCas12a with enhanced activity through directional evolution in human cells

Clustered regularly interspaced short palindromic repeat–Cas12a has been harnessed to manipulate the human genome; however, low cleavage efficiency and stringent protospacer adjacent motif hinder the use of Cas12a-based therapy and applications. Here, we have described a directional evolving and scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiexie, Liu, Xiaoyu, Zhou, Chenchen, Lv, Jineng, He, Xiubin, Liu, Yuanyuan, Xie, Haihua, Wang, Bang, Lv, Xiujuan, Tang, Lianchao, Li, Mingchun, Liu, Changbao, Zhao, Junzhao, Liu, Yong, Song, Zongming, Gu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961096/
https://www.ncbi.nlm.nih.gov/pubmed/33567342
http://dx.doi.org/10.1016/j.jbc.2021.100394
Descripción
Sumario:Clustered regularly interspaced short palindromic repeat–Cas12a has been harnessed to manipulate the human genome; however, low cleavage efficiency and stringent protospacer adjacent motif hinder the use of Cas12a-based therapy and applications. Here, we have described a directional evolving and screening system in human cells to identify novel FnCas12a variants with high activity. By using this system, we identified IV-79 (enhanced activity FnCas12a, eaFnCas12a), which possessed higher DNA cleavage activity than WT FnCas12a. Furthermore, to widen the target selection spectrum, eaFnCas12a was engineered through site-directed mutagenesis. eaFnCas12a and one engineered variant (eaFnCas12a-RR), used for correcting human RS1 mutation responsible for X-linked retinoschisis, had a 3.28- to 4.04-fold improved activity compared with WT. Collectively, eaFnCas12a and its engineered variants can be used for genome-editing applications that requires high activity.

Ejemplares similares